Internal Medicine

Hands-on medical simulation, simplified

Elizabeth Sanseau of CHOP and Annenberg’s Kyle Cassidy discuss Annenberg Hotkeys, a medical simulator developed during the pandemic to remotely prepare health care providers for emergency situations.

Marilyn Perkins

The Pavilion at year one

It’s been one year since Penn Medicine celebrated the opening of the Pavilion, designed as a “hospital of the future” with advancements in patient care, collaborative research, and innovative environmental design.

From Penn Medicine News

In the News

Medical News Today

Cardiovascular disease: New tool may help predict risk in people with chronic kidney disease

Researchers at the Perelman School of Medicine have developed a new, more accurate risk model for cardiovascular disease in patients with chronic kidney disease.



$50 million gift to University of Pennsylvania for autoimmune disease research

A $50 million gift from Wharton School alumni Judy and Stewart Colton will further develop the work of the Colton Center for Autoimmunity at the Perelman School of Medicine, with a statement from President Liz Magill.


Philadelphia Inquirer

$50 million gift to Penn is aimed at new treatments for autoimmune disease

E. John Wherry of the Perelman School of Medicine hopes to find better answers for autoimmune conditions as director of the Colton Center for Autoimmunity, established and now accelerated by alumni Judy and Stewart Colton.


The Scientist

Armored CAR T cells break through immune suppression in solid tumors

A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer.



New treatment target could counter bone loss

A study from Shuying (Sheri) Yang of the School of Dental Medicine and colleagues identified a protein that regulates osteoclasts, the cells that break down bone, which may pave the way for new treatments that prevent bone loss.


Personalized immunotherapy shows promise beyond cancer

Carl June of the Perelman School of Medicine is interviewed on the use of customized immunotherapy to treat new blood cancers, as well as its potential for treating solid state cancers and autoimmune diseases.